Mexico Fund (MXF) 15.60 $MXF The Mexico Fund, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mexico Fund (MXF) 15.60 $MXF

The Mexico Fund, Inc. Announces Change in Distribution Rate of Its Managed Distribution Plan and Declares Distribution
Marketwire Canada - Tue Sep 13, 7:01AM CDT
WASHINGTON, DC--(Marketwired - Sep 13, 2016) - The Mexico Fund, Inc. (NYSE: MXF) announced today that the Board of Directors (Board) approved a change in the quarterly distribution payable under the Fund´s Managed Distribution Plan (MDP), effective with the distribution to be paid in October 2016. The Board implemented the MDP in September 2008, and believes it has served the Fund and its stockholders well; since then, the Fund has made quarterly cash distributions during 33 consecutive quarters for a total of $21.50 per share. Under the guidance of Impulsora del Fondo México, S.C., the Fund's Investment Adviser since inception in 1981, the annual return of the Fund's net asset value (NAV) has outperformed the MSCI Mexico Index, the Fund's benchmark, over the past 1, 3, 5 and 10 year periods ended August 31, 2016.
MXF: 15.60 (-0.26)

The Mexico Fund, Inc. Declares Distribution
Marketwire Canada - Mon Jun 06, 8:41AM CDT
WASHINGTON, DC--(Marketwired - Jun 6, 2016) - The Mexico Fund, Inc. (NYSE: MXF) announced that the Board of Directors (Board) declared a distribution of $0.2831 per share to stockholders of record on July 14, 2016, which is payable in cash on July 26, 2016. This distribution is the second corresponding to the fiscal year 2016.
MXF: 15.60 (-0.26)

The Mexico Fund, Inc. Pays Distribution
Marketwired - Tue Apr 26, 8:32AM CDT
The Mexico Fund, Inc. (NYSE: MXF) announced that it will pay today a distribution of $0.2831 per share in cash to stockholders of record as of April 14, 2016. According to the terms of the Fund's Managed Distribution Plan (MDP), this distribution is the equivalent of 1.5% of the Fund's net asset value per share (NAV) as of December 31, 2015.
MXF: 15.60 (-0.26)

The Mexico Fund, Inc. Announces 2016 Annual Meeting of Stockholders
Marketwired - Thu Jan 07, 7:00AM CST
The Mexico Fund, Inc. (NYSE: MXF) announced today that it will conduct its Annual Meeting of Stockholders on March 16, 2016, for stockholders of record as of the close of business on January 27, 2016. The meeting will be held at 9:30 am CST at the John Jacob Boardroom of The St. Regis Houston Hotel, on the Mezzanine Level, located at 1919 Briar Oaks Lane, Houston, Texas, 77027, for the following purposes:
MXF: 15.60 (-0.26)

The Mexico Fund, Inc. Declares Distribution and Ratifies Continuation of Managed Distribution Plan for Fiscal 2016
Marketwired - Mon Dec 07, 7:30AM CST
The Mexico Fund, Inc. (NYSE: MXF) announced that the Board of Directors (Board) declared a distribution of $0.3396 per share to stockholders of record on December 23, 2015, which is payable in cash on January 13, 2016. This distribution is the last corresponding to the fiscal year 2015.
MXF: 15.60 (-0.26)

Downtrend Call Working As The Mexico Fund Stock Falls 14.4% (MXF)
Comtex SmarTrend(R) - Wed Sep 16, 4:58PM CDT
SmarTrend identified a Downtrend for The Mexico Fund (NYSE:MXF) on June 30th, 2015 at $21.14. In approximately 3 months, The Mexico Fund has returned 14.43% as of today's recent price of $18.09.
MXF: 15.60 (-0.26)

The Mexico Fund Has Returned 15.6% Since SmarTrend Recommendation (MXF)
Comtex SmarTrend(R) - Mon Aug 31, 5:11PM CDT
SmarTrend identified a Downtrend for The Mexico Fund (NYSE:MXF) on June 30th, 2015 at $21.14. In approximately 2 months, The Mexico Fund has returned 15.61% as of today's recent price of $17.84.
MXF: 15.60 (-0.26)

16.1% Return Seen to Date on SmarTrend The Mexico Fund Call (MXF)
Comtex SmarTrend(R) - Thu Aug 20, 11:46AM CDT
SmarTrend identified a Downtrend for The Mexico Fund (NYSE:MXF) on June 30th, 2015 at $21.14. In approximately 2 months, The Mexico Fund has returned 16.12% as of today's recent price of $17.73.
MXF: 15.60 (-0.26)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immuron Advances IMM-529 Development Following FDA Feedback

Updated Category News Views 289

Immuron Charts Path for Phase 2 Trial of IMM-529 Key Highlights Immuron concludes an important pre-IND meeting with the FDA regarding IMM-529, aimed at combating Clostridioides difficile infection (CDI). Previous clinical trials highlight the necessity for ongoing development of IMM-529. The company plans to submit an IND application for IMM-529 in the first half of 2025.

Continue Reading
Enefit Green to Host Webinars for Unveiling 2024 Results

Updated Category News Views 123

Join Enefit Green's Upcoming Webinars on 2024 Results Enefit Green is set to announce its Q4 and annual unaudited results for 2024. The special reveal will occur shortly after the publication of the report, allowing shareholders and investors to gain critical insights into the company's financial standing. Webinar Schedule and Details The webinars will be hosted on the...

Continue Reading
Intapp's Encouraging Earnings Fuel Stock Surge Amid Market Momentum

Updated Category News Views 197

Intapp's Strong Earnings Report Captivates Investors On a positive note for investors, U.S. stocks saw an uplifting day, with the Dow Jones index climbing approximately 250 points. The highlight of the day was the impressive performance of Intapp, Inc. Shares of Intapp, Inc. (NASDAQ: INTA) experienced a sharp increase following the company's announcement of...

Continue Reading
NewAmsterdam Pharma's Upcoming Conference Participation for 2024

Updated Category News Views 229

NewAmsterdam Pharma Announces Conference Participation NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is gearing up for an exciting lineup of presentations at key medical and investor conferences. As a leader in developing innovative oral therapies for cardiovascular disease, NewAmsterdam is set to share groundbreaking research findings and engage with stakeholders in...

Continue Reading
John Hancock Funds Announce Monthly Distribution Updates

Updated Category News Views 366

Monthly Distribution Announcements from John Hancock Funds John Hancock has announced important updates regarding the distributions for its closed-end funds. These monthly distributions aim to provide returns to investors, ensuring they receive value from their investments in a timely manner. Details of the Monthly Distribution Declaration Key Dates Recently, the board of...

Continue Reading